LATEST
TALKS
Health conversations from across the globe in topics ranging from equity, equality, research, access, education, technology value and discovery.
Over 100 years of Advancing Pharmacy Worldwide
Clinical research and trials in the Australia and New Zealand region offer foreign companies an opportunity to collaborate with local institutions, tap into diverse patient populations, access high-quality healthcare infrastructure, and gain regulatory approvals, enabling them to expand their market reach and accelerate the development of innovative medical interventions.
Clinical trials continued in Australia and New Zealand during lockdown, thanks to collaboration between industry and government, allowing the region to attract trials from other countries.
Clinical research and trials in Australia and New Zealand
Clinical research and trials in the Australia and New Zealand region offer foreign companies an opportunity to collaborate with local institutions, tap into diverse patient populations, access high-quality healthcare infrastructure, and gain regulatory approvals, enabling them to expand their market reach and accelerate the development of innovative medical interventions.
Clinical trials continued in Australia and New Zealand during lockdown, thanks to collaboration between industry and government, allowing the region to attract trials from other countries.
Lifelong research into Cannabis
Mechoulam was possibly the most significant academic to shed light on the active principles of the cannabis plant back in the 1960s, when his work at the Weizmann Institute led to the discovery of the human endo-cannabinoid system, giving him the title the “Godfather of cannabis research”. In a recent Global Health Talk with Michael Lesner, Professor Mechoulam reflects on his lifelong work in cannabis research.
Transformative era for medical devices in Asia-Pacific region
APACMed has formed partnerships in the region, but also with MedTech Innovator based in the United States for screening startups in the Asia Pacific region. This reflects 40% of APACmed members being multinational MedTech companies. However 50% of APACMed members are startups from the region itself.
The Asia Pacific MedTech market is forecasted to become the 2nd largest in the world, yet has varying levels of maturity across a diverse number of countries. The region also has large numbers of the ageing population, but spends less than 5% on average in healthcare, for a region where the main disease states are in cardiovascular, orthpedics and diabetes.
Accelerating technology and innovation in pediatrics
Medical devices in pediatrics is an underserved area due to the characteristics of the patient. Children are usually less likely to be sick, the regulatory and ethical complexity treating children and lastly, the changing nature of growing children’s bodies creating its own challenges.
Support for pediatric medical technology innovators commenced under Consortium for Technology & Innovation in Pediatrics (known as CTIP), has been through the PDC program funded by the US FDA in 2009. To date there have been 4 cycles of the program.
Equitable learning opportunities for new nurses
With over 130,000 students at Western Governors University (WGU) delivering online courses from the US, Dr Jan Jones-Schenk is the Senior Vice President and Executive Dean of the College of Health Professions. The College that Dr Jones-Schenk is Dean of, has approximately 30,000 students following healthcare curricula.
In January 2022, the University marks 25 years as a non-profit academic institution, focused on competency based education delivered through expanded access to rural areas and in an equitable manner to others in the United States. The focus for WGU has been in delivering education regardless of time or place especially in rural communities to locals.
Veteran wellbeing in civilian life
In an informal talk with Global Health Talks host Mike Lesner, himself a former US Marine, Nicci talks on the purpose of AIMS being an information-sharing network for all those who serve and support the military and veteran community.
Access to services is important consideration for Veteran wellbeing and AIMS develops a user-friendly membership infrastructure where members can network; research and information can be curated and archived; Service members, Veterans, Families, and caregivers can easily access services.
Another of the important roles that AIMS serves is to enhance partnership with VA and government services to increase efficiency and fill gaps.
Preventing surgery related infections
Surgical site infections (SSI) is infection that occurs after surgery in a part of the body where the surgery took place. Surgical site infections are seen as the most common healthcare-associated infection, significantly impacting healthcare resources in the UK and across the World.
Professor Leaper speaks on needing ongoing good antibiotic stewardship to reduce the risk of antibiotic-resistant and emergent organisms. The pressures on administering antibiotics have led to tighter management and stewardship of antibiotics.
Technology to reach global health equity
Dr Terry Knapp, MD as a plastic and reconstructive plastic surgeon, has given back to medicine and global health through over 35 overseas trips as a volunteer surgeon. He is also an inventor with 16 medical device and technology patents to his name. His entrepreneurial spirit has led to founding 6 successful companies, leading to today being the Founder and Chief Medical Officer of CareSpan Health.
Health equity, in technology driven health care delivery, is determined by access to the clinician, specifically communications medical technology. CareSpan Health developed an integrated digital care ecosystem. The architecture of which became, Clinic in the Cloud.
Australia’s digital health push into new national markets
Infection rates following surgical procedure vary across countries, however the causes and the ranges of variation are not well understood.
The causes of the infections are not as high as would be assumed on the surgical procedure, but co-morbidity and lifestyle choices including alcohol consumption may exacerbate risk. As Dr Edmiston states, there are a myriad of causes, and funding is limited in many countries. However there are some solutions, where goals, performance tracking against the goals and better communication is needed.
Global effort to reduce postoperative infection risk
Infection rates following surgical procedure vary across countries, however the causes and the ranges of variation are not well understood.
The causes of the infections are not as high as would be assumed on the surgical procedure, but co-morbidity and lifestyle choices including alcohol consumption may exacerbate risk. As Dr Edmiston states, there are a myriad of causes, and funding is limited in many countries. However there are some solutions, where goals, performance tracking against the goals and better communication is needed.